characteristics.text: SAMN36416704
characteristics.characteristic: External Id
characteristics.text: IRCCS Humanitas Research Hospital
characteristics.characteristic: INSDC center name
characteristics.text: 2025-05-16T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2025-05-16T22:26:07.573Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS18269409
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS18269409
characteristics.characteristic: SRA accession
characteristics.text: Ccr2- macrophages
characteristics.characteristic: cell type
characteristics.text: missing
characteristics.characteristic: collection_date
characteristics.text: ApoE KO
characteristics.characteristic: genotype
characteristics.text: missing
characteristics.characteristic: geo_loc_name
characteristics.text: Mus musculus
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_10090
characteristics.characteristic: organism
characteristics.text: Ccr2- macrophages
characteristics.characteristic: source_name
characteristics.text: 12 weeks treatment
characteristics.characteristic: time
characteristics.text: Ccr2- Dapa HFD 2
characteristics.characteristic: title
characteristics.text: intragastric dapagliflozin (AstraZeneca) through gavage, 1.0 mg/kg/d for 12-weeks
characteristics.characteristic: treatment
characteristics.text: high fat diet
characteristics.characteristic: treatment